New mutations in the human p53 gene--a regulator of the cell cycle and carcinogenesis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The p53 tumor suppressor gene plays a critical role in maintaining cellular genetic integrity.
• Disruptions in p53 function are frequently observed in various cancers, including colorectal cancer.
• p53 mutations can lead to uncontrolled cell division and tumor development.

Purpose of the Study:

• To investigate the spectrum and frequency of p53 gene mutations in primary colorectal tumors.
• To identify novel p53 isoforms resulting from mutations or alternative splicing.
• To correlate p53 mutation status with clinical parameters and patient prognosis.

Main Methods:

• Analysis of p53 gene mutations in 26 primary colorectal tumors.
• Sequencing of exons 4-8 to detect point mutations within the DNA binding domain.
• Identification of altered p53 isoforms through frameshift mutations or abnormal splicing.

Main Results:

• p53 mutations were identified in 65.4% (17 out of 26) of the colorectal tumors analyzed.
• All detected point mutations were located in the DNA binding domain, specifically within exons 4-8.
• Six tumors exhibited mutant p53 isoforms, including novel variants p53-305 and p53i9*, and previously unreported mutations Leu111Gln and Ser127Phe.

Conclusions:

• p53 gene mutations are prevalent in colorectal cancer and primarily affect the DNA binding domain.
• Novel p53 isoforms and mutations were discovered, expanding the understanding of p53 alterations in this cancer.
• p53 mutations in colorectal cancer are significantly associated with lymph node metastasis and advanced tumor stage (III/IV), suggesting an unfavorable prognosis.